Alberto Álvarez-Larrán

25PUBLICATIONS
113CO-AUTHORS
Haematological tumoursRespiratory diseasesEpidemiological modellingMedical mycologyCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|May 07, 2026
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera.

|Nov 24, 2025
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.

Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|Apr 17, 2025
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.

Lucía Pérez-Lamas, Adrián Segura Diaz, Regina García Delgado

|Feb 03, 2025
Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry.

Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio

Pageof 5

Frequent Collaborators

12 joint publications

Juan-Carlos Hernández-Boluda

9 joint publications

Francisca Ferrer-Marin

7 joint publications

Valentín García-Gutiérrez

5 joint publications

Gonzalo Carreño-Tarragona